ZINC, COPPER AND MAGNESIUM KINETICS DURING DESFERRIOXAMINE TREATMENT IN UREMIC PATIENTS

被引：3

作者：

SEGOLONI, GP ^{[1
]}

CANAVESE, C ^{[1
]}

DAMICONE, M ^{[1
]}

LAMON, S ^{[1
]}

TALARICO, S ^{[1
]}

VERCELLONE, A ^{[1
]}

机构：

[1] UNIV TURIN,SAN GIOVANNI MOLINETTE HOSP,DEPT TOXICOL,I-10131 TORINO,ITALY

来源：

NEPHRON | 1984年 / 36卷 / 04期

关键词：

D O I：

10.1159/000183171

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：278 / 279

页数：2

共 14 条

[1]

ACKRILL P, 1980, LANCET, V2, P692

[2] REVERSAL OF ALUMINUM DIALYSIS ENCEPHALOPATHY AFTER DESFERRIOXAMINE TREATMENT [J].

ARZE, RS ;

PARKINSON, IS ;

CARTLIDGE, NEF ;

BRITTON, P ;

WARD, MK .

LANCET, 1981, 2 (8255) :1116-1116

[3]

Baker L R, 1976, Clin Nephrol, V6, P326

[4]

BROWN DJ, 1982, LANCET, V2, P343

[5] THE USE OF MAGNESIUM-CONTAINING PHOSPHATE BINDERS IN PATIENTS WITH END-STAGE RENAL-DISEASE ON MAINTENANCE HEMODIALYSIS [J].

GUILLOT, AP ;

HOOD, VL ;

RUNGE, CF ;

GENNARI, FJ .

NEPHRON, 1982, 30 (02) :114-117

[6]

MCCARTHY JT, 1982, MAYO CLIN PROC, V57, P439

[7]

MILNE FJ, 1982, LANCET, V2, P502

[8]

MION C, 1981, T AM SOC ART INT ORG, V27, P634

[9]

MOUNTOKALAKIS T, 1979, CLIN NEPHROL, V12, P206

[10]

MUDDE AH, 1982, LANCET, V2, P608

← 1 2 →